stocks
524703-BOM

Sandu Pharmaceuticals Ltd.

41.00+0.4 (+1.11%)
10 Jul, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
39.61
P/E (TTM)
22.43
P/B
0.91
P/S (TTM)
0.57
EV/EBITDA
9.45
CAPE (5Y)
24.33
ROE (TTM)
4.12
ROCE (TTM)
5.37
ROA (TTM)
3.17
Avg 3Y ROE
3.84
Earnings 3Y CAGR
4.32
Sales 3Y CAGR
2.29
Sales 5Y CAGR
3.54
Debt/Equity
0.01
Consensus TP
-
Strong Buy %
-
Promoter Holding
37.79
Pledged %
0.00

Share Price

Track Sandu Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -1.44 %
Low
40.2
High
42.0
1 Month returns: -0.10 %
Low
39.9
High
45.5
1 Year returns: -17.34 %
Low
30.0
High
58.3
3 Year CAGR: -7.62 %
Low
30.0
High
85.0
5 Year CAGR: -5.66 %
Low
30.0
High
86.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Sandu Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Sandu Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Sandu Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Sandu Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Sandu Pharmaceuticals Ltd.?
The current share price of Sandu Pharmaceuticals Ltd. is ₹ 41.00 as of 10 Jul 2026.
What is the market capitalisation of Sandu Pharmaceuticals Ltd.?
The market capitalisation of Sandu Pharmaceuticals Ltd. stands at ₹ 39.61 Cr.
What is the PE ratio of Sandu Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Sandu Pharmaceuticals Ltd. is 22.43 as of the latest trailing twelve months data.
What is the ROE and ROCE of Sandu Pharmaceuticals Ltd.?
Sandu Pharmaceuticals Ltd. has a Return on Equity (ROE) of 4.12% and a Return on Capital Employed (ROCE) of 5.37% as per the latest financial reports.
What is the 52-week high and low of Sandu Pharmaceuticals Ltd.?
The 52-week high of Sandu Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Sandu Pharmaceuticals Ltd.?
The dividend yield of Sandu Pharmaceuticals Ltd. is 1.95% based on the current market price.
What is the FII and DII holding in Sandu Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 38.94% of Sandu Pharmaceuticals Ltd. shares.
What sector does Sandu Pharmaceuticals Ltd. belong to?
Sandu Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Sandu Pharmaceuticals Ltd.?
The beta of Sandu Pharmaceuticals Ltd. is 0.63, indicating its price volatility relative to the broader market. Over the past 1 year, Sandu Pharmaceuticals Ltd. has delivered an absolute return of -18.02%.
What is the RSI of Sandu Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Sandu Pharmaceuticals Ltd. is 46.66, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.